Integrin β1 Increases Stem Cell Survival and Cardiac Function after Myocardial Infarction

Area of Science:

• Regenerative Medicine
• Cardiovascular Biology
• Stem Cell Biology

Background:

• Bone mesenchymal stem cells (BMSCs) show therapeutic potential for myocardial infarction (MI).
• Poor BMSC survival limits their efficacy in treating MI.
• Integrin β1 is investigated as a target to enhance BMSC viability.

Purpose of the Study:

• To improve the survival and therapeutic efficacy of BMSCs for MI treatment.
• To investigate the role of integrin β1 overexpression in BMSC survival and function.
• To evaluate the impact of integrin β1-overexpressing BMSCs on cardiac function post-MI.

Main Methods:

• Overexpression of integrin β1 in BMSCs using lentivirus vectors.
• In vitro assessment of BMSC proliferation and apoptosis markers under stress conditions.
• Intramyocardial transplantation of modified BMSCs in a rat MI model.
• Evaluation of BMSC survival, cardiac function, and molecular changes post-transplantation.

Main Results:

• Integrin β1 overexpression enhanced BMSC proliferation under oxygen-glucose deprivation and modulated apoptosis-related proteins (Caspase-3, Bax, Bcl-2) and signaling molecules (FAK, ILK).
• Transplanted integrin β1-overexpressing BMSCs exhibited higher survival rates in the MI heart.
• Significant improvement in cardiac function and reduced cardiomyocyte apoptosis were observed in the integrin β1-BMSC group, with increased expression of Bcl-2, FAK, ILK, and VEGF.

Conclusions:

• Integrin β1 overexpression significantly enhances the survival of transplanted BMSCs.
• This strategy improves cardiac function and reduces apoptosis in a myocardial infarction model.
• Adhesion-mediated cell survival signaling pathways are implicated in the beneficial effects of integrin β1 on BMSCs and cardiomyocytes.